Maravai LifeSciences Reports First Quarter 2024 Financial Results
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: GlobeNewswire
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2024, together with other business updates. Financial Highlights: Quarterly revenue of $64.2 million, Net loss of $(22.7) million, and Adjusted EBITDA of $7.8 million; andReaffirmed financial guidance for the full year 2024 including a revenue range of $265.0 million to $285.0 million. Partnerships and Innovation: TriLink BioTechnologies and Lonza entered into a Non-exclusive License and Supply Agreement for CleanCap® M6, CleanCap® AG 3’OMe, CleanCap® AG, and CleanCap® AU cap analogs for use in Lonza’s global mRNA development and manufacturing services;TriLink BioTechnologies recently launched 21 new catalog mRNA products, incorporating CleanCap® M6, N1-methyl-pseudouridine, and o
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best [Yahoo! Finance]Yahoo! Finance
- RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One [Seeking Alpha]Seeking Alpha
- MNMD, NBIX and OCUL are among after hour movers [Seeking Alpha]Seeking Alpha
- Maravai (MRVI) Advances in RNA Research With New Collaboration [Yahoo! Finance]Yahoo! Finance
- TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center [Yahoo! Finance]Yahoo! Finance
MRVI
Earnings
- 5/8/24 - Beat
MRVI
Sec Filings
- 6/12/24 - Form 8-K
- 6/10/24 - Form SC
- 5/30/24 - Form 4
- MRVI's page on the SEC website